A meta-analysis on the EBV DNA and VCA-IgA in diagnosis of Nasopharyngeal Carcinoma
- PMID: 24353651
- PMCID: PMC3809314
- DOI: 10.12669/pjms.293.2907
A meta-analysis on the EBV DNA and VCA-IgA in diagnosis of Nasopharyngeal Carcinoma
Abstract
Objective: We conducted a meta-analysis to compare the EBV DNA and VCA-IgA in diagnosis of Nasopharyngeal Carcinoma, and provide important evidence for screening method of NPC.
Methodology: Three databases, Medline (from Jan. 1966 to Jan. 2012), EMBASE (from January 1988 to Jan. 2012) and Chinese Biomedical Database (from January 1980 to Jan. 2012) were used to detect the role of EBV DNA and VCA-IgA in diagnosis of NPC. Meta-DiSc statistical software was used for analysis.
Results: Twenty seven case-control and cohort studies were included in final analysis. A total of 1554 cases and 2932 controls were included in our meta-analysis. The Sensitivity specificity, positive likelihood (+LR) and likelihood negative (-LR) of EBV-DNA in diagnosis of NPC were 0.75(0.72-0.76), 0.87(0.85-0.88), 6.98(4.50-10.83) and 0.18(0.11-0.29), respectively, and they were 0.83(0.81-0.85), 0.85(0.83-0.86), 10.89(5.41-21.93) and 0.20(0.14-0.29) for VCA-IgA. The SROC for EBV DNA detection was 0.939, while this was 0.936 for VCA-IgA detection. The subgroup analysis showed EBV-DNA had larger areas under the summary receiver operator curve when compared with VCA-IgA in high quality and low quality studies.
Conclusion: Our meta-analysis indicated the EBV DNA had higher sensitivity and specificity in diagnosis of NPC.
Keywords: DNA; Diagnosis; Epstein-Barr virus (EBV); Nasopharyngeal Carcinoma; VCA-IgA.
Figures
Similar articles
-
The diagnostic value of EBV-DNA and EBV-related antibodies detection for nasopharyngeal carcinoma: a meta-analysis.Cancer Cell Int. 2021 Mar 10;21(1):164. doi: 10.1186/s12935-021-01862-7. Cancer Cell Int. 2021. PMID: 33691680 Free PMC article. Review.
-
[Assessment of detection assays of Epstein-Barr viral Rta-IgG, VCA-IgA, EA-IgA and Epstein-Barr viral DNA at different clinical stages in the diagnosis of nasopharyngeal carcinoma].Zhonghua Yi Xue Za Zhi. 2013 Nov 26;93(44):3516-9. Zhonghua Yi Xue Za Zhi. 2013. PMID: 24521892 Chinese.
-
Diagnostic Value of Serum Epstein-Barr Virus Capsid Antigen-IgA for Nasopharyngeal Carcinoma: a Meta-Analysis Based on 21 Studies.Clin Lab. 2016;62(6):1155-66. doi: 10.7754/clin.lab.2015.151122. Clin Lab. 2016. PMID: 27468579 Review.
-
Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.Pathol Oncol Res. 2020 Oct;26(4):2185-2190. doi: 10.1007/s12253-020-00808-0. Epub 2020 Mar 28. Pathol Oncol Res. 2020. PMID: 32222897
-
Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody.Clin Chem. 2004 Feb;50(2):339-45. doi: 10.1373/clinchem.2003.022426. Epub 2003 Dec 18. Clin Chem. 2004. PMID: 14684618
Cited by
-
Elevated levels of plasma D-dimer predict a worse outcome in patients with nasopharyngeal carcinoma.BMC Cancer. 2014 Aug 10;14:583. doi: 10.1186/1471-2407-14-583. BMC Cancer. 2014. PMID: 25109220 Free PMC article.
-
Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era.PLoS One. 2015 Apr 13;10(4):e0122965. doi: 10.1371/journal.pone.0122965. eCollection 2015. PLoS One. 2015. PMID: 25874450 Free PMC article.
-
The association between circulating tumor cells and Epstein-Barr virus activation in patients with nasopharyngeal carcinoma.Cancer Biol Ther. 2017 Nov 2;18(11):888-894. doi: 10.1080/15384047.2017.1281493. Epub 2017 Jan 25. Cancer Biol Ther. 2017. PMID: 28121221 Free PMC article.
-
Nasopharyngeal carcinoma: A new synthesis of literature data (Review).Exp Ther Med. 2022 Feb;23(2):136. doi: 10.3892/etm.2021.11059. Epub 2021 Dec 13. Exp Ther Med. 2022. PMID: 35069817 Free PMC article. Review.
-
Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect.J Transl Med. 2023 Nov 6;21(1):786. doi: 10.1186/s12967-023-04673-8. J Transl Med. 2023. PMID: 37932756 Free PMC article. Review.
References
-
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–08. - PubMed
-
- Henle G, Henle W. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer. 1976;17:1–7. - PubMed
-
- Zeng Y, Zhang LG, Wu YC, Huang YS, Huang NQ, Li JY, et al. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou city, China. Int J Cancer. 1985;36(5):545–547. - PubMed
-
- Cheng WM, Chan KH, Chen HL, Luo RX, Ng SP, Luk W, et al. Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum. Int J Cancer. 2002;97(4):489–492. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous